NCHIV 2019 will take place on 13 Nov

The 12th Netherlands Conference on HIV Pathogenesis, Epidemiology, Prevention and Treatment (NCHIV) is set to take place at the Royal Tropical Institute (KIT) in Amsterdam on Wednesday 13 November 2019.


Registration for NCHIV 2019 opens 6 May 2019. Click on the button below to register.

NCHIV 2019 registration fees

  • Standard registration: € 185.00
  • Postgraduate students/A(N)OIS/nurse/nurse practitioner: € 125.00
  • Undergraduate students only: € 50.00

For accreditation, click here

Register here

Abstract submission

We encourage submission of innovative research across relevant scientific disciplines that advances the field and has been conducted by Netherlands-based researchers either within or outside the Netherlands.

Read abstract guidelines here

Abstract submission closes 6 September (9 AM CET)

Submit abstract

Preliminary programme: sessions, speaker and preliminary titles

  • Keynote (Cure): Dr. Anthony Fauci (NIH/NIAID, Bethesda, USA)
    • Ending the HIV Pandemic: Challenges and Opportunities
  • Plenary (Treatment): Prof. Chloe Orkin (Barts Health NHS Trust, London, UK)
    • ART: a changing landscape
  • Plenary (Epidemiology): Dr. Karoline Aebi-Popp (University Hospital Bern, Switzerland)
    • Challenges and needs for women living with HIV: From conception to infancy
  • Plenary (Prevention): Prof. Wafaa El-Sadr (Columbia University, New York, USA)
    • Bringing Precision to the Global HIV Response

Please note: titles of plenary talks are subject to change

In line with previous years, sessions will also include oral abstract presentations, selected from the highest scoring submitted abstracts. All abstracts undergo blinded peer-review by a panel of experts.

Poster presentations can be viewed during the lunchbreak.

Joep Lange & Jacqueline van Tongeren Junior Investigator’s Award

This year the scientific programme committee will once again select the best abstract submitted by a junior scientist to be awarded the Joep Lange & Jacqueline van Tongeren Junior Investigator’s Award.

To be considered for the award, authors must be in the process of gaining or have recently gained their PhD. In addition, the abstract must relate to work carried out in gaining their PhD.

The winning abstract author will be given the opportunity to present their abstract as an oral presentation during one of the conference sessions. They will also receive a prize to the value of €1000 to be spent within one year of NCHIV 2019 on research-related costs, such as textbooks or attending a conference.

The winning author will be announced during the final conference session.

NCHIV provides an update and platform for discussion of new insights and developments in research on the pathogenesis, epidemiology, prevention and treatment of HIV. The one-day programme has three key elements: a core programme of sessions focussed on each of these four research themes; an extended lunch programme with poster presentations; and four invited plenary speakers.

NCHIV is organised by